Your browser doesn't support javascript.
loading
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
Torlot, Lucien; Jarzab, Anna; Albert, Johanna; Pók-Udvari, Ágnes; Stahler, Arndt; Holch, Julian Walter; Gerlinger, Marco; Heinemann, Volker; Klauschen, Frederick; Kirchner, Thomas; Kumbrink, Jörg; Küster, Bernhard; Jung, Andreas.
Afiliación
  • Torlot L; Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Jarzab A; German Cancer Consortium (DKTK), Heidelberg, Munich Site, Germany.
  • Albert J; Chair or Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
  • Pók-Udvari Á; Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Stahler A; Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Holch JW; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gerlinger M; German Cancer Consortium (DKTK), Heidelberg, Berlin, Germany.
  • Heinemann V; German Cancer Consortium (DKTK), Heidelberg, Munich Site, Germany.
  • Klauschen F; Department of Medicine III, LMU Hospital, Munich, Germany.
  • Kirchner T; Comprehensive Cancer Center Munich (CCCM), LMU Hospital, Munich, Germany.
  • Kumbrink J; Translational Oncogenomics Lab, The Institute of Cancer Research, London, UK.
  • Küster B; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Jung A; Gastrointestinal Cancer Unit, St Bartholomew's Hospital, London, UK.
J Cancer Res Clin Oncol ; 149(2): 669-682, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36401637

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antineoplásicos Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antineoplásicos Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania